The Nobel Prize in Chemistry

Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers

LinkedIn Top Startups 2024: The 50 U.S. companies on the rise

Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors

Alumis files for IPO to support work on oral TYK2 blockers

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D

Inscripta Acquires Infinome Biosciences, Sestina Bio

BIOS Builders Interview with Mark Chao, Co-founder & CEO at TenSixteen Bio

Foresite Labs’ new $173M fund to bankroll fewer startups but ‘big ideas’ fueled by data

Foresite Capital Launches $173M Fund to Support Incubated Companies